Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information. OR Written assent and parental/legal guardian consent.
Age \>= 6 and \< =21 years at the time of diagnosis.
Newly- diagnosed with one of the following diseases: B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Written informed consent to participate in the caregiver interviews.
The caregiver must be a parent or legal guardian ≥ 18 years old, and their child must be \<18 years
You may not be if
Subjects must not be receiving any investigational or additional anti-cancer medicines during induction.
Significant concurrent disease, illness, or psychiatric disorder or social issue that would compromise subject safety or adherence to the protocol treatment or procedures, interfere with consent, study participation, follow-up, or interpretation of the study results.